Pfizer Inc. boosts its oncology pipeline with strategic control of PD-1/VEGF bispecific drugs via 3SBio deal. Click for more ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

Pfizer share price gained 13% in the intraday trades on Tuesday post Q4 Results, dividend announcement and despite stock ...

The highest dividend-paying stocks in the S&P 500 right now are blue-chip stocks that yield anywhere between 6.2% and 9.3% annually. And while markets are largely flat since Jan. 1 — with a ...

U.S. drugmaker Pfizer said it would license an experimental cancer treatment from China's 3SBio Inc , paying $1.25 billion ...

Shares of Honda India Power and HLE Glascoat were locked in a 20 per cent upper circuit on Tuesday after their profit doubled in Q4FY25 ...

Today, companies across sectors including DLF, Pfizer, Zydus Wellness, One Mobikwik Systems, Restaurant Brands Asia, Bharat ...